No Data
Even After Rising 10% This Past Week, Genscript Biotech (HKG:1548) Shareholders Are Still Down 67% Over the Past Three Years
Is the rebound trend of Hong Kong stocks established? The Hang Seng Index temporarily returned to 20,000 points, and the performance of Cryptos stocks is eye-catching.
① How do Institutions view the phenomenon of the Hong Kong stock market warming up? ② What news primarily drives the rising trend of pharmaceutical stocks?
Hong Kong stocks are experiencing unusual movements | CRO Concept stocks are leading in gains as the医保丙类目录 is expected to be implemented this year, and Domestic Innovative Drugs are likely to open up payment space.
CRO Concept stocks have risen significantly. As of the time of writing, WUXI APPTEC (02359) rose by 6.36%, trading at 55.2 HKD; GENSCRIPT BIO (01548) increased by 5.64%, trading at 9.93 HKD; WUXI BIO (02269) went up by 5.9%, priced at 19.02 HKD; and PHARMARON (03759) rose by 4.66%, trading at 13.92 HKD.
GenScript Upgrades Product Packaging With a Recyclable Strategy, Reducing Waste by 82% and Contributing to Environmental Sustainability
China Securities Co.,Ltd.: An outlook on the pharmaceutical Industry 2024 annual report.
In 2025, the Industry is expected to achieve moderate growth and overall move towards high-quality development.
An alternative "going abroad" for centralized procurement of pharmaceuticals and medical devices? The China-ASEAN regional centralized procurement platform for pharmaceuticals has been launched, and the industry anticipates the birth of the first Order.
① Today, the China-ASEAN pharmaceutical regional procurement platform officially launched, with representatives from Shenzhen Mindray Bio-Medical Electronics, United Imaging Healthcare, SIMCERE PHARMA, and other companies present; ② Although the specific implementation plan is yet to be clarified, the industry believes it is undoubtedly Bullish for domestic pharmaceutical companies; ③ The Southeast Asian pharmaceutical market is growing rapidly, but it relies heavily on imported drugs and medical devices.
Genscript Biotech Corporation's (HKG:1548) P/S Is Still On The Mark Following 29% Share Price Bounce
No Data
